ArticleOphthalmology and therapy2026

Study Design for ELARA, a Phase 3b Trial of Aflibercept 8 mg in Previously Treated Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema.

David M Brown et al.PubMed ↗Publisher ↗

No numbers read from the abstract.